KR100624501B1 - 매트릭스형 경피 치료 시스템 및 그 제조 방법 - Google Patents
매트릭스형 경피 치료 시스템 및 그 제조 방법 Download PDFInfo
- Publication number
- KR100624501B1 KR100624501B1 KR1020027012010A KR20027012010A KR100624501B1 KR 100624501 B1 KR100624501 B1 KR 100624501B1 KR 1020027012010 A KR1020027012010 A KR 1020027012010A KR 20027012010 A KR20027012010 A KR 20027012010A KR 100624501 B1 KR100624501 B1 KR 100624501B1
- Authority
- KR
- South Korea
- Prior art keywords
- matrix
- polymer
- layer
- hydrophobic
- active material
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Abstract
Description
Claims (14)
- 활성물질 비투과성 지지층, 분리형 보호층, 및 소수성 중합체를 기제로 하는 활성물질 함유 매트릭스로 구성되며, 그 활성물질은 실온 이상의 용융점을 갖고 경피 치료 시스템의 적어도 일부 부착시간 동안 포화 용해도를 넘는 농도로 존재하는 매트릭스형 경피 치료 시스템으로서,상기 소수성 중합체를 함유하는 매트릭스층에, 폴리아크릴레이트를 기제로 하는 자기접착성 친수성 피부 접촉층이 마련되어 있음을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제1항에 있어서,상기 활성물질 함유 매트릭스가 소수성 기제 중합체로서 폴리실록산류, 또는 폴리이소부틸렌, 폴리이소프렌 또는 스티렌-디엔-스티렌 블록 공중합체, 또는 상기 소수성 중합체들의 혼합물을 포함함을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 삭제
- 제1항에 있어서,폴리아크릴레이트가 상기 활성물질 함유 매트릭스의 소수성 기제 중합체(들)에 혼합되어 있음을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제1항에 있어서,폴리비닐피롤리돈, 또는 폴리비닐피롤리돈과 비닐아세테이트의 공중합체가 상기 활성물질 함유 매트릭스의 소수성 기제 중합체(들) 또는 적어도 상기 피부 접촉층에 혼합되어 있음을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제1항에 있어서,상기 피부 접촉층이 자기접착성 폴리아크릴레이트와 친수성 중합체의 혼합물임을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제6항에 있어서,상기 친수성 중합체가 폴리비닐피롤리돈, 또는 비닐피롤리돈과 비닐아세테이트의 공중합체임을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제1항, 제2항, 및 제4항 내지 제7항 중 어느 한 항에 있어서,상기 시스템은, 단지 피부에 부착한 후에만 수분 흡수 또는 용제의 방출에 의해 활성물질에 대하여 과포화된 상태에 도달함을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 삭제
- a) 소수성 기제 중합체 및 활성물질을 함유하는 용액 또는 분산액을 제조하는 공정;b) 상기 중합체 및 활성물질 함유 덩어리를 접착성이 부여된 필름 상에 얇게 도포한 후, 건조시키는 공정;c) 아크릴레이트 중합체 및 필요에 따라 친수성 막형성 중합체, 또는 아크릴레이트 중합체 및 필요에 따라 친수성 막형성 중합체를 혼합한 소수성 중합체를 함유하는 도포 덩어리를 사용하여, 공정 a) 및 b)에 의해 제2층(피부 접촉층)을 형성하는 공정;d) 공정 b)에서 얻어진 매트릭스층으로부터 접착성 필름을 제거하는 공정;e) 공정 b)에서 얻어진 매트릭스층을 공정 c)에서 얻어진 피부 접촉층에 적층하는 공정;f) 상기 매트릭스층에 지지층을 적층하는 공정; 및g) 개개의 경피 치료 시스템을 펀칭해내는 공정을 특징으로 하는, 제1항, 제2항, 제6항, 및 제7항 중 어느 한 항 기재의, 친수성 피부 접촉층을 포함하는 매트릭스형 경피 치료 시스템의 제조 방법.
- 제4항에 있어서,폴리아크릴레이트의 양이 전체 매트릭스에 대하여 10중량%∼40중량%임을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제5항에 있어서,상기 소수성 기제 중합체에 혼합된 중합체들의 양이 전체 매트릭스에 대하여 10중량%∼40중량%임을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제2항에 있어서,상기 폴리실록산류가 내아민성임을 특징으로 하는 매트릭스형 경피 치료 시스템.
- 제10항에 있어서,상기 공정 a)에서, 소수성 기제 중합체 및 활성물질에 폴리아크릴레이트를 혼합하는 것을 특징으로 하는 매트릭스형 경피 치료 시스템의 제조 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10012908A DE10012908B4 (de) | 2000-03-16 | 2000-03-16 | Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung |
DE10012908.0 | 2000-03-16 | ||
PCT/EP2001/002449 WO2001068060A2 (de) | 2000-03-16 | 2001-03-05 | Stabilisierte übersättigte transdermale therapeutische matrixsysteme |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030007462A KR20030007462A (ko) | 2003-01-23 |
KR100624501B1 true KR100624501B1 (ko) | 2006-09-18 |
Family
ID=7635008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027012010A KR100624501B1 (ko) | 2000-03-16 | 2001-03-05 | 매트릭스형 경피 치료 시스템 및 그 제조 방법 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030099695A1 (ko) |
EP (1) | EP1263417B1 (ko) |
JP (2) | JP5111710B2 (ko) |
KR (1) | KR100624501B1 (ko) |
CN (1) | CN1281209C (ko) |
DE (1) | DE10012908B4 (ko) |
ES (1) | ES2674044T3 (ko) |
WO (1) | WO2001068060A2 (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10137405A1 (de) * | 2001-07-31 | 2003-02-20 | Beiersdorf Ag | Verfahren zur kontinuierlichen Herstellung und Beschichtung von Selbstklebemassen auf Basis von SBC mit mindestens einem pharmazeutischen Wirkstoff |
DE10211832A1 (de) * | 2002-03-16 | 2003-10-02 | Lohmann Therapie Syst Lts | Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion |
DE10212864B4 (de) * | 2002-03-22 | 2005-12-22 | Beiersdorf Ag | Polymermatrizes umfassend ein Mischsystem zur Löslichkeitsvermittlung von pharmazeutischen Wirkstoffen, Verfahren zu deren Herstellung und deren Verwendung |
DE10330971B4 (de) | 2003-07-08 | 2007-03-29 | Beiersdorf Ag | Verfahren zur Herstellung von Haut- oder Wundauflagen mit verkapselten, wundheilungsfördernden und/oder hautpflegenden Substanzen |
US20050118246A1 (en) * | 2003-10-31 | 2005-06-02 | Wong Patrick S. | Dosage forms and layered deposition processes for fabricating dosage forms |
DE10360592A1 (de) * | 2003-12-19 | 2005-07-28 | Beiersdorf Ag | Pflastersystem zur Verabreichung von Antihistaminika |
DE102004038533A1 (de) | 2004-08-09 | 2006-02-23 | Beiersdorf Ag | Wasserhaltige Polymermatrix aus hydrophoben Polymeren |
DE102004062182B4 (de) * | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
KR100663163B1 (ko) | 2005-10-24 | 2007-01-02 | (주)아모레퍼시픽 | 비스테로이드성 소염진통제를 함유하는 경피 투여 제제 |
US20080075779A1 (en) * | 2006-09-27 | 2008-03-27 | Chappa Ralph A | Additives And Methods For Enhancing Active Agent Elution Kinetics |
DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
DE102006054732B4 (de) | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
US11147722B2 (en) * | 2008-11-10 | 2021-10-19 | Kimberly-Clark Worldwide, Inc. | Absorbent article with a multifunctional acrylate skin-adhesive composition |
DE102011090178A1 (de) | 2011-12-30 | 2013-07-04 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit geringer Neigung zur Spontankristallisation |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
NL2010639C2 (en) * | 2013-04-15 | 2014-10-16 | Nutripol Capital S A R L | Hydrophobic polymers. |
ES2694662T3 (es) | 2013-07-03 | 2018-12-26 | Lts Lohmann Therapie-Systeme Ag | Sistema terapéutico transdérmico con componente electrónico |
ES2954087T3 (es) | 2014-05-20 | 2023-11-20 | Lts Lohmann Therapie Systeme Ag | Sistema de administración transdérmica que incluye un mediador de interfase |
JP6895755B2 (ja) | 2014-05-20 | 2021-06-30 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮送達システムにおける活性薬剤の放出を調節するための方法 |
US11633367B2 (en) | 2014-05-20 | 2023-04-25 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system containing rotigotine |
WO2019068288A1 (de) | 2017-10-04 | 2019-04-11 | Berlimed International Research Gmbh | Wirkstoff und wirkstoffmatrix enthaltendes produkt zur transdermalen wirkstoffabgabe sowie dessen herstellung und verwendung sowie die wirkstoffmatrix, ihre herstellung und verwendung |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6054314A (ja) * | 1983-09-02 | 1985-03-28 | Sekisui Chem Co Ltd | 治療用貼付製剤 |
US5364628A (en) * | 1985-05-31 | 1994-11-15 | Sandoz Ltd. | Pharmaceutical compositions |
US5145682A (en) * | 1986-05-30 | 1992-09-08 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
AU601528B2 (en) * | 1986-12-22 | 1990-09-13 | Ortho-Mcneil Pharmaceutical, Inc. | Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers |
GB8704755D0 (en) * | 1987-02-28 | 1987-04-01 | Dow Corning Ltd | Pharmaceutical delivery device |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
DE4339400A1 (de) * | 1993-11-18 | 1995-05-24 | Hexal Pharma Gmbh | Wirkstoffpflaster |
US5906830A (en) * | 1995-09-08 | 1999-05-25 | Cygnus, Inc. | Supersaturated transdermal drug delivery systems, and methods for manufacturing the same |
JPH09301853A (ja) * | 1996-05-14 | 1997-11-25 | Nitto Denko Corp | 貼付剤および貼付製剤 |
US5928666A (en) * | 1996-11-12 | 1999-07-27 | Cygnus Inc. | Crystalline form of estradiol and pharmaceutical formulations comprising same |
DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
DE19814084B4 (de) * | 1998-03-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung |
DE19834505A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transdermales therapeutisches System zur Anwendung von Sildenafil |
AU5325000A (en) * | 1999-06-05 | 2000-12-28 | David Houze | Solubility enhancement of drugs in transdermal drug delivery systems and methodsof use |
-
2000
- 2000-03-16 DE DE10012908A patent/DE10012908B4/de not_active Expired - Lifetime
-
2001
- 2001-03-05 ES ES01936058.5T patent/ES2674044T3/es not_active Expired - Lifetime
- 2001-03-05 CN CNB018065848A patent/CN1281209C/zh not_active Expired - Lifetime
- 2001-03-05 JP JP2001566624A patent/JP5111710B2/ja not_active Expired - Fee Related
- 2001-03-05 WO PCT/EP2001/002449 patent/WO2001068060A2/de active Application Filing
- 2001-03-05 KR KR1020027012010A patent/KR100624501B1/ko active IP Right Grant
- 2001-03-05 EP EP01936058.5A patent/EP1263417B1/de not_active Expired - Lifetime
- 2001-03-05 US US10/221,650 patent/US20030099695A1/en not_active Abandoned
-
2011
- 2011-11-04 JP JP2011242745A patent/JP2012056958A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1263417B1 (de) | 2018-05-02 |
DE10012908A1 (de) | 2001-10-04 |
JP2012056958A (ja) | 2012-03-22 |
JP2003526656A (ja) | 2003-09-09 |
ES2674044T3 (es) | 2018-06-27 |
WO2001068060A3 (de) | 2002-02-07 |
CN1418092A (zh) | 2003-05-14 |
CN1281209C (zh) | 2006-10-25 |
KR20030007462A (ko) | 2003-01-23 |
WO2001068060A2 (de) | 2001-09-20 |
JP5111710B2 (ja) | 2013-01-09 |
DE10012908B4 (de) | 2005-03-17 |
EP1263417A2 (de) | 2002-12-11 |
US20030099695A1 (en) | 2003-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100624501B1 (ko) | 매트릭스형 경피 치료 시스템 및 그 제조 방법 | |
TWI435737B (zh) | 經皮遞送醫藥化合物的方法及其組成物 | |
KR100895188B1 (ko) | 활성성분으로서 펜타닐을 함유하는 경피치료 시스템 | |
US20040057985A1 (en) | Transdermal therapeutic system comprising the active ingredient oxybutynin | |
EP1827398B1 (de) | Transdermales therapeutisches system mit aktivierbarer übersättigung und kontrollierter permeationsförderung | |
KR20010036685A (ko) | 펜타닐을 함유하는 매트릭스형 경피투여제 | |
HU223042B1 (hu) | Parkinson-kór kezelésére alkalmas hatóanyagot tartalmazó tapasz | |
JP2006514977A (ja) | カプサイシンを含むポリシロキサンマトリックスを有する治療パッチ | |
US5714162A (en) | Scopolamine patch | |
CZ20014514A3 (cs) | Mikrorezervoárový systém na bázi polysiloxanů a ambifilních rozpouątědel | |
JP2003528037A (ja) | 気管支拡張剤ツロブテロールを皮膚から投与するための塩酸ツロブテロールを含む経皮治療システム | |
US20060039960A1 (en) | Plaster containing fentanyl | |
KR100549846B1 (ko) | 활성물질 스코폴라민 염기를 함유하는 경피 치료 시스템 | |
JP2001514226A5 (ko) | ||
EP2068847B1 (en) | Preparation and composition of meloxicam transdermal drug delivery system | |
JPH02149514A (ja) | 医薬部材 | |
SK22097A3 (en) | Transdermal therapeutic system and a method for producing same | |
KR100394830B1 (ko) | 스코폴아민패치 | |
CZ2000716A3 (cs) | Transdermální terapeutický systém s basí skopolaminu jako účinnou látkou |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120903 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130830 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140901 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150828 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160829 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170901 Year of fee payment: 12 |